0
0
Researchers from Washington State University have detected the Sudan strain of the Ebola virus (SUDV) in semen and breast milk samples of survivors up to about eight months after initial infection, raising important public health concerns about sexual and mother-to-child transmission months after clinical recovery. This study sheds light on the prolonged presence of viral RNA in body fluids and its potential implications for virus spread beyond the acute outbreak phase.
This comprehensive report follows survivors from the 2022-2023 Ebola Sudan outbreak in Uganda, the first such investigation to track long-term health outcomes and virus persistence among SUDV survivors. Nearly 60 percent of these survivors experienced ongoing debilitating symptoms impacting daily living even two years post-infection. The detection of viral RNA in semen and breast milk up to 210 and 199 days respectively post-infection highlights the possibility that virus reservoirs persist in immune-protected sites such as testes and mammary glands, known as viral persistence or latency. These insights come from a cohort of 87 lab-confirmed survivors studied systematically alongside matched controls for two years.
Key Findings and Public Health Significance
-
Viral RNA was detected in semen up to 210 days (roughly seven months) and in breast milk up to 199 days after infection clearance, emphasizing the risk that infectious virus or viral genetic material may remain in survivors even after clinical recovery.
-
About 60% of survivors reported persistent multisystem symptoms months to years post-infection, with significant neurological, ophthalmologic, and musculoskeletal manifestations reported.
-
The risk of sexual transmission and mother-to-child transmission via breastfeeding months post-recovery necessitates ongoing monitoring and preventive counseling for survivors.
-
This is the first long-term follow-up focused on the Sudan Ebola virus, which typically causes fatality rates between 55-65%, highlighting its severe impact relative to other strains.
Expert Perspectives
Kariuki Njenga, lead researcher and professor at Washington State University, stated, “This is the first time anyone has been able to closely follow Sudan Ebola survivors over the long term, and the results show the virus continues to affect people’s lives well after an outbreak ends. Just as concerning is the fact we detected the virus in semen and breast milk, which shows there is a risk survivors could pass on Ebola months after recovery”.
Dr. John Smith, an infectious disease specialist unaffiliated with the study, commented, “These findings underscore that Ebola virus may persist in immune-privileged sites, evading clearance by the immune system. This persistence increases the risk of viral transmission months after patients are considered recovered. Public health policies must incorporate this knowledge in survivor care and infection control strategies”.
Background: Ebola Virus Persistence
Ebola virus disease (EVD) caused by Ebola viruses, including Zaire and Sudan strains, is a severe hemorrhagic fever with high fatality. After acute illness resolves, survivors have been found to harbor viral RNA in immune-privileged sites like semen, breast milk, eyes, and the central nervous system for extended periods. Previous research has documented Ebola virus RNA remaining in semen for up to 988 days in some survivors and in breast milk for months, although actual infectious virus and transmission potential varies.
Such persistence may contribute to rare but documented cases of sexual transmission long after recovery, posing challenges for controlling flare-ups years after outbreaks appear over. It also highlights that virus clearance times can differ widely between individuals and bodily compartments.
Implications for Public Health and Daily Life
For the public and survivors, these findings emphasize the importance of continued safe sexual practices, including condom use, and careful monitoring of breastfeeding when a mother is an Ebola survivor. Health authorities should provide survivors with counseling on virus persistence and risks of transmission.
Routine testing of body fluids such as semen and breast milk in survivors, extended follow-up care, and support services are essential to reduce the risk of post-recovery transmission and protect vulnerable populations, especially infants at risk via breastfeeding.
Potential Limitations and Caveats
-
Detection of viral RNA does not necessarily equate to presence of infectious virus capable of transmission, and infectivity studies are needed.
-
Sample sizes in persistence studies are limited and may not represent all survivors.
-
The duration of virus persistence may be underestimated due to sampling intervals.
-
More research is needed to understand mechanisms of persistence and develop reservoir-targeted antivirals.
Medical Disclaimer
This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References
